Wellington Management opposes Celgene deal

Note: This section contains information in English only.
Source: Dukascopy Bank SA

Wellington Management, the top Bristol-Myers Squibb's shareholder, stated it would not support the US drugmaker's $74B worth takeover of the biotech firm Celgene.

Actual Topics